118 related articles for article (PubMed ID: 28262199)
1. Effects of Disease Activity and Inflammatory Response on Hypercoagulability in Patients with Systemic Lupus Erythematosus.
Liang Y; Leng RX; Pan HF; Ye DQ
Arch Med Res; 2016 Oct; 47(7):573-579. PubMed ID: 28262199
[TBL] [Abstract][Full Text] [Related]
2. The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional study.
Liang Y; Leng RX; Pan HF; Ye DQ
Rheumatol Int; 2017 Feb; 37(2):305-311. PubMed ID: 27999942
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein and complement components but not other acute-phase reactants discriminate between clinical subsets and organ damage in systemic lupus erythematosus.
Amezcua-Guerra LM; Springall R; Arrieta-Alvarado AA; Rodríguez V; Rivera-Martinez E; Castillo-Martinez D; Bojalil R
Clin Lab; 2011; 57(7-8):607-13. PubMed ID: 21888025
[TBL] [Abstract][Full Text] [Related]
4. The ratio of erythrocyte sedimentation rate to C-reactive protein is useful in distinguishing infection from flare in systemic lupus erythematosus patients presenting with fever.
Littlejohn E; Marder W; Lewis E; Francis S; Jackish J; McCune WJ; Somers EC
Lupus; 2018 Jun; 27(7):1123-1129. PubMed ID: 29546774
[TBL] [Abstract][Full Text] [Related]
5. Impact of markers of endothelial injury and hypercoagulability on systemic lupus erythematosus.
Cicarini WB; Duarte RCF; Ferreira KS; Loures CMG; Consoli RV; Neiva CLS; de Pádua PM; Nunes FFC; Alves LCV; Reis EA; Moreira CC; Guimarães TMPD; de Toledo VPCP; Carvalho MDG
Lupus; 2020 Feb; 29(2):182-190. PubMed ID: 31948350
[TBL] [Abstract][Full Text] [Related]
6. The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland.
Ribi C; Trendelenburg M; Gayet-Ageron A; Cohen C; Dayer E; Eisenberger U; Hauser T; Hunziker T; Leimgruber A; Lindner G; Koenig K; Otto P; Spertini F; Stoll T; Von Kempis J; Chizzolini C;
Swiss Med Wkly; 2014; 144():w13990. PubMed ID: 25115978
[TBL] [Abstract][Full Text] [Related]
7. Serum Wisteria floribunda agglutinin-positive Mac-2-binding protein can reflect systemic lupus erythematosus activity.
Ahn SS; Park Y; Lee DD; Bothwell ALM; Jung SM; Song JJ; Park YB; Lee SW
Lupus; 2018 Apr; 27(5):771-779. PubMed ID: 29233037
[TBL] [Abstract][Full Text] [Related]
8. Features associated with pulmonary arterial hypertension in Chinese hospitalized systemic lupus erythematosus patients.
Xu SZ; Yan Liang ; Li XP; Li XM; Shuai ZW; Leng RX; Pan HF; Ye DQ
Clin Rheumatol; 2018 Jun; 37(6):1547-1553. PubMed ID: 29520672
[TBL] [Abstract][Full Text] [Related]
9. High-sensitivity C-reactive protein and erythrocyte sedimentation rate in systemic lupus erythematosus.
Firooz N; Albert DA; Wallace DJ; Ishimori M; Berel D; Weisman MH
Lupus; 2011 May; 20(6):588-97. PubMed ID: 21436216
[TBL] [Abstract][Full Text] [Related]
10. The Relationship between Erythrocyte Sedimentation Rate and Erythrocyte Sedimentation/Red Blood Cell Ratio and Disease Activity in Systemic Lupus Erythematosus.
Xiao LJ; Liu JL; Pan NN; Cui SJ; He HH; Ren TY; Lan X; Li Q; Zhou YW
Clin Lab; 2020 Mar; 66(3):. PubMed ID: 32162871
[TBL] [Abstract][Full Text] [Related]
11. Serum matrix metalloproteinase-3 and fibrin degradation product levels correlate with clinical disease activity in rheumatoid arthritis.
Ichikawa Y; Yamada C; Horiki T; Hoshina Y; Uchiyama M
Clin Exp Rheumatol; 1998; 16(5):533-40. PubMed ID: 9779299
[TBL] [Abstract][Full Text] [Related]
12. Red blood cell distribution width is a potential index to assess the disease activity of systemic lupus erythematosus.
Hu ZD; Chen Y; Zhang L; Sun Y; Huang YL; Wang QQ; Xu YL; Chen SX; Qin Q; Deng AM
Clin Chim Acta; 2013 Oct; 425():202-5. PubMed ID: 23954839
[TBL] [Abstract][Full Text] [Related]
13. Does erythrocyte sedimentation rate reflect and discriminate flare from infection in systemic lupus erythematosus? Correlation with clinical and laboratory parameters of disease activity.
Schäfer VS; Weiß K; Krause A; Schmidt WA
Clin Rheumatol; 2018 Jul; 37(7):1835-1844. PubMed ID: 29656375
[TBL] [Abstract][Full Text] [Related]
14. Fibrinogen in systemic lupus erythematosus: more than an acute phase reactant?
Ames PR; Alves J; Pap AF; Ramos P; Khamashta MA; Hughes GR
J Rheumatol; 2000 May; 27(5):1190-5. PubMed ID: 10813286
[TBL] [Abstract][Full Text] [Related]
15. Is there still a place for erythrocyte sedimentation rate and C-reactive protein in systemic lupus erythematosus?
Dima A; Opris D; Jurcut C; Baicus C
Lupus; 2016 Oct; 25(11):1173-9. PubMed ID: 27256317
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosus.
Heshmat NM; El-Kerdany TH
Pediatr Allergy Immunol; 2007 Jun; 18(4):346-53. PubMed ID: 17346298
[TBL] [Abstract][Full Text] [Related]
17. [Blood coagulation changes in systemic lupus erythematosus].
Liu WL; Xiu HZ; Sun HY
Zhonghua Nei Ke Za Zhi; 1990 Dec; 29(12):717-9, 764. PubMed ID: 2128740
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and risk factors of infections in patients with systemic lupus erythematosus.
Hou C; Jin O; Zhang X
Clin Rheumatol; 2018 Oct; 37(10):2699-2705. PubMed ID: 29987426
[TBL] [Abstract][Full Text] [Related]
19. Urine β2-microglobulin is associated with clinical disease activity and renal involvement in female patients with systemic lupus erythematosus.
Choe JY; Park SH; Kim SK
Lupus; 2014 Dec; 23(14):1486-93. PubMed ID: 25124677
[TBL] [Abstract][Full Text] [Related]
20. [Analysis of traditional cardiovascular risk factors in patients with systemic lupus erythematosus].
Liu L; Zhang T; Ye Y; Zhang S; Chen L
Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Sep; 42(9):753-8. PubMed ID: 25511096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
